Munich Re: How are GLP-1 medications and AI technologies impacting life insurance?

2025 life science report from Munich Re reveals the effects of medications, like Ozempic and Wegovy, on mortality rates and life insurance underwriting.

You will be redirected in 10 seconds.

liveinternet liveinternet